UNIGE document Scientific Article - Review
previous document  unige:150556  next document
add to browser collection
Title

Locally advanced pancreatic ductal adenocarcinoma: challenges and progress

Authors
Barcellini, Amelia
Pugliese, Luigi
Vitolo, Viviana
Cobianchi, Lorenzo
Published in OncoTargets and therapy. 2020, vol. 13, p. 12705-12720
Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the major causes of death in the Western world, and it is estimated to become the second leading cause of tumour-related mortality in the next 10 years. Among pancreatic cancers, ductal adenocarcinomas are by far the most common, characterised by a challenging diagnosis due to the lack of initial and pathognomonic clinical signs. In this scenario, non-metastatic locally advanced pancreatic cancer (LAPC) accounts for a large proportion of all new pancreatic ductal adenocarcinoma diagnoses. There is no consensus on a common definition of LAPC. Still, it usually includes tumours that are not resectable due to vascular involvement. As of today, treatment is limited, and the prognosis is very unfavourable. Curative-intent surgery remains the gold-standard even if often jeopardized by vascular involvement. Continuing progress in our understanding of LAPC genetics and immunology will permit the development of different treatments, targeted or combined, including radiation therapy, hadrontherapy, targeted immunotherapies or new chemotherapies. A multidisciplinary approach combining various fields of expertise is essential in aiming to limit disease progression as well as patient outcome. Using a narrative literature review approach, the manuscript explores the most up-to-date knowledge concerning locally advanced pancreatic ductal adenocarcinoma management.
Keywords HadrontherapyPancreatic cancerRisk factorsSurgeryTreatment
Identifiers
PMID: 33335406
Full text
Structures
Research group Transplantation et hépatologie (905)
Citation
(ISO format)
BARCELLINI, Amelia et al. Locally advanced pancreatic ductal adenocarcinoma: challenges and progress. In: OncoTargets and therapy, 2020, vol. 13, p. 12705-12720. doi: 10.2147/OTT.S220971 https://archive-ouverte.unige.ch/unige:150556

40 hits

14 downloads

Update

Deposited on : 2021-03-22

Export document
Format :
Citation style :